Linked e-resources
Details
Table of Contents
Chapter 1: Definition and Prevalence of Cancer-Related Fatigue; 1.1 Introduction; 1.2 Physiologic Fatigue; 1.3 Pathologic Fatigue; 1.4 Cancer-Related Fatigue; 1.5 Epidemiology and Prevalence Rates; 1.6 Clinical Manifestation; 1.7 Impact of Fatigue; References; Chapter 2: Etiology and Pathogenesis of Cancer-Related Fatigue; 2.1 Introduction; 2.2 Symptom Clustering and Inflammation; 2.2.1 Sickness Behavior Syndrome; 2.2.2 Fatigue and the Central Nervous System; 2.2.3 Genetic Factors; References; Chapter 3: Diagnosis and Assessment; 3.1 Introduction; 3.2 Diagnostic Criteria
3.3 Assessment Considerations3.4 Clinical Assessment; 3.5 Psychological Assessment; 3.6 Assessment Scales; 3.6.1 Revised Piper Fatigue Scale; 3.6.2 Fatigue Symptom Inventory; 3.6.3 Multidimensional Fatigue Inventory; 3.6.4 Brief Fatigue Inventory; 3.6.5 Schwartz Cancer Fatigue Scale; 3.6.6 Functional Assessment of Cancer Therapy
Fatigue Scale; 3.6.7 Fatigue Assessment Questionnaire; 3.6.8 Cancer Fatigue Scale; 3.6.9 European Organization for Research and Treatment of Cancer Quality of Life Questionnaire
Fatigue; 3.7 Assessment Procedures; References
Chapter 4: Nonpharmacological Treatment4.1 Introduction; 4.2 Psychosocial Interventions; 4.2.1 Information and Counseling; 4.2.2 Psychoeducation; 4.2.3 Cognitive Behavioral Therapy; 4.3 Mind-Body Interventions; 4.3.1 Mindfulness-Based Stress Reduction; 4.3.2 Yoga; 4.4 Exercise and Sports Therapy; References; Chapter 5: Pharmacological Treatment; 5.1 Introduction; 5.2 Stimulants; 5.2.1 Methylphenidate; 5.2.2 Modafinil; 5.3 Erythropoiesis-Stimulating Agents; 5.4 Antidepressants; 5.5 Corticosteroids; 5.6 Thyrotropin-Releasing Hormone; 5.7 Phytotherapeutic Agents; 5.7.1 Ginseng
5.7.2 Guarana (Paullinia cupana)5.7.3 Other Herbal Drugs; References; Chapter 6: Recommendations for the Management of Cancer-Related Fatigue; 6.1 Introduction; 6.2 Screening and Assessment; 6.3 Information and Counseling; 6.4 Cancer-Related Fatigue During Cancer Treatment; 6.5 Persisting Cancer-Related Fatigue; 6.6 Fatigue in the Palliative Situation; References
3.3 Assessment Considerations3.4 Clinical Assessment; 3.5 Psychological Assessment; 3.6 Assessment Scales; 3.6.1 Revised Piper Fatigue Scale; 3.6.2 Fatigue Symptom Inventory; 3.6.3 Multidimensional Fatigue Inventory; 3.6.4 Brief Fatigue Inventory; 3.6.5 Schwartz Cancer Fatigue Scale; 3.6.6 Functional Assessment of Cancer Therapy
Fatigue Scale; 3.6.7 Fatigue Assessment Questionnaire; 3.6.8 Cancer Fatigue Scale; 3.6.9 European Organization for Research and Treatment of Cancer Quality of Life Questionnaire
Fatigue; 3.7 Assessment Procedures; References
Chapter 4: Nonpharmacological Treatment4.1 Introduction; 4.2 Psychosocial Interventions; 4.2.1 Information and Counseling; 4.2.2 Psychoeducation; 4.2.3 Cognitive Behavioral Therapy; 4.3 Mind-Body Interventions; 4.3.1 Mindfulness-Based Stress Reduction; 4.3.2 Yoga; 4.4 Exercise and Sports Therapy; References; Chapter 5: Pharmacological Treatment; 5.1 Introduction; 5.2 Stimulants; 5.2.1 Methylphenidate; 5.2.2 Modafinil; 5.3 Erythropoiesis-Stimulating Agents; 5.4 Antidepressants; 5.5 Corticosteroids; 5.6 Thyrotropin-Releasing Hormone; 5.7 Phytotherapeutic Agents; 5.7.1 Ginseng
5.7.2 Guarana (Paullinia cupana)5.7.3 Other Herbal Drugs; References; Chapter 6: Recommendations for the Management of Cancer-Related Fatigue; 6.1 Introduction; 6.2 Screening and Assessment; 6.3 Information and Counseling; 6.4 Cancer-Related Fatigue During Cancer Treatment; 6.5 Persisting Cancer-Related Fatigue; 6.6 Fatigue in the Palliative Situation; References